Share
- Release Date: 17/01/13 17:22
- Summary: NTA: MLN: MLN NAV $0.8361 as at 15/1/13
- Price Sensitive: No
- Download Document 1.44KB
MLN
17/01/2013 15:22
NTA
REL: 1522 HRS Marlin Global Limited
NTA: MLN: MLN NAV $0.8361 as at 15/1/13
MLN NAV $0.8361 as at 15/1/13
Date 15/1/2013 8/1/2013
MLN NAV $0.8361 $0.8305
Share price close $0.71 $0.68
Discount 15% 18%
The above NAV is unaudited.
The NAV per share is after deducting treasury stock (shares acquired under
the Marlin Global buyback programme).
The five largest portfolio holdings at 15 January 2013 are approximately as
follows:
Biotest (Germany) 6%
Wasion (China) 4%
Stratec Biomedical (Germany) 4%
Sarin Technologies (Israel) 4%
Tom Tailor (Germany) 4%
BACKGROUND
Marlin Global is a listed investment company that invests in growing
companies based outside of New Zealand and Australia. The Marlin portfolio is
managed by Fisher Funds, a specialist investment manager with a track record
of successfully investing in growth company shares. The aim of Marlin is to
offer investors competitive returns through capital growth and dividends, and
access to a diversified portfolio of investments through a single,
tax-efficient investment vehicle. Marlin listed on the NZX Main Board on 1
November 2007 and may invest in companies that are listed on any approved
stock exchange (excluding New Zealand or Australia) or unlisted international
companies not incorporated in New Zealand or Australia.
For further information please contact Marlin Global Limited, ph (09) 484
0365.
End CA:00232119 For:MLN Type:NTA Time:2013-01-17 15:22:36
